CR 3465
Alternative Names: Leukotriene CYS-LT1 - Rottapharm; Leukotriene LTD4 antagonists - RottapharmLatest Information Update: 19 May 2016
At a glance
- Originator Rottapharm
- Developer Rottapharm Madaus
- Class Aromatic amino acids; Small molecules
- Mechanism of Action Leukotriene D4 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Asthma; Interstitial cystitis
Most Recent Events
- 23 Oct 2014 CR 3465 is still in phase I trials for Asthma and Interstitial cystitis in Italy
- 10 Oct 2014 Rottapharm Madaus has been acquired by Meda
- 24 Feb 2010 Preclinical trials in Interstitial cystitis in Italy (PO)